APREX Trademark
Trademark Overview
On Thursday, July 13, 1995, a trademark application was filed for APREX with the United States Patent and Trademark Office. The USPTO has given the APREX trademark a serial number of 74700492. The federal status of this trademark filing is ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE as of Tuesday, August 27, 1996. This trademark is owned by Pfizer, Inc.. The APREX trademark is filed in the Pharmaceutical Products category with the following description:
pharmaceutical preparation having anti-inflammatory properties
General Information
Serial Number | 74700492 |
Word Mark | APREX |
Filing Date | Thursday, July 13, 1995 |
Status | 602 - ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE |
Status Date | Tuesday, August 27, 1996 |
Registration Number | 0000000 |
Registration Date | NOT AVAILABLE |
Mark Drawing | 1000 - Typeset: Word(s) / letter(s) / number(s) |
Published for Opposition Date | NOT AVAILABLE |
Trademark Statements
Goods and Services | pharmaceutical preparation having anti-inflammatory properties |
Classification Information
International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
US Class Codes | 006, 018, 044, 046, 051, 052 |
Class Status Code | 8 - Abandoned |
Class Status Date | Wednesday, August 4, 1999 |
Primary Code | 005 |
First Use Anywhere Date | NOT AVAILABLE |
First Use In Commerce Date | NOT AVAILABLE |
Trademark Owner History
Party Name | Pfizer, Inc. |
Party Type | 10 - Original Applicant |
Legal Entity Type | 03 - Corporation |
Address | New York, NY 10017 |
Trademark Events
Event Date | Event Description |
Tuesday, August 27, 1996 | ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE |
Thursday, January 4, 1996 | NON-FINAL ACTION MAILED |
Friday, December 22, 1995 | ASSIGNED TO EXAMINER |